ZELTIQ Announces Location and Agenda for 2013 Investor Day
August 27 2013 - 8:30AM
ZELTIQ®, (Nasdaq:ZLTQ) a medical technology company focused on
developing and commercializing products utilizing its proprietary
controlled-cooling technology platform, today announced the
location, agenda and RSVP information for its 2013 investor and
analyst day. The event will be held on September 17th, 2013 from
10:00 a.m. ET to 12:00 p.m. ET at the Sheraton Times Square, 811
7th Ave., New York, NY.
The event will highlight the Company's technology and growth
strategy and will include an interactive panel of physicians who
will discuss CoolSculpting® and the market for non-invasive body
contouring.
Please RSVP by emailing:
Okhan@theruthgroup.com or calling
646-536-7006 by September 6, 2013.
Event: ZELTIQ Investor
Day |
Date: September 17,
2013 |
Time: 10:00
a.m. ET to 12:00 p.m. ET. |
Location:
Sheraton Times Square, 811 7th Ave., New York, NY |
The agenda will include:
- Executive Management Presentations on Corporate Strategy,
Growth Drivers and Market Dynamics
- Q&A with Executive Management
- Presentation by Dr. Grant Stevens on CoolSculpting use in his
practice
- Interactive Physician Panel with Audience Q&A
ZELTIQ is honored to welcome the following physicians as
participants on the panel:
- Grant Stevens, M.D., F.A.C.S. – Marina Plastic Surgery, Los
Angeles, CA
- Lori A. Brightman, M.D., F.A.A.D. – Laser and Skin Surgery
Center, New York, NY
- David P. Rapaport, M.D., F.A.C.S. – Park Avenue Plastic
Surgeon, New York, NY
An audio web cast with live slide presentations will be
available by visiting the investor relations section of ZELTIQ's
web site at www.coolsculpting.com. A replay of the presentation
will be available for 90 days.
About ZELTIQ®
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first commercial
product, the CoolSculpting System, is designed to selectively
reduce stubborn fat that may not respond to diet or exercise.
CoolSculpting is based on the scientific principle that fat cells
are more sensitive to cold than the overlying skin and surrounding
tissues. It utilizes patented technology of precisely controlled
cooling to reduce the temperature of fat cells in the treated area,
which is intended to cause fat cell elimination through a natural
biological process known as apoptosis. ZELTIQ developed
CoolSculpting to safely, noticeably, and measurably reduce the fat
layer.
CONTACT: Investor Relations:
Patrick F. Williams
ZELTIQ, Senior Vice President and CFO
925-474-2500
Nick Laudico
The Ruth Group
646-536-7030
nlaudico@theruthgroup.com
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024